Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07046585 · ClinicalTrials.gov registry record
Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
A clinical trial of Colo-rectal Cancer, sponsored by Natera.
- Recruiting
- Registry status
- 25,000
- Enrollment target
- 1
- Study location
NCT07046585 is a study of Colo-rectal Cancer that is actively recruiting participants, run by Natera. The registered enrollment target is 25,000 participants, above the 534-participant average among 11 other Colo-rectal Cancer trials with a reported enrollment target (4582% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07046585, a study of Colo-rectal Cancer, is actively recruiting participants, sponsored by Natera.
- RECRUITING
- Registry status
- 25,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The FIND-CRC study is a prospective collection of samples and data from participants who are at average risk of developing colorectal cancer (CRC). Collected samples and data will be analyzed to evaluate the clinical performance of the Natera CRC Screening Test.
Conditions Studied
Study Locations (1)
Texas
- Natera, Inc - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,000 participants |
| Start Date | 2025-05-30 |
| Est. Completion | 2033-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07046585
The ClinicalTrials.gov registry entry for NCT07046585 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 534-participant average among 11 other Colo-rectal Cancer trials with a reported enrollment target (4582% higher). The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colo-rectal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT07046585 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07046585 about?
NCT07046585 is a clinical study titled "Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)". The FIND-CRC study is a prospective collection of samples and data from participants who are at average risk of developing colorectal cancer (CRC). Collected samples and data will be analyzed to evaluate the clinical performance of the Natera CRC Screening Test.
What is the current status of trial NCT07046585?
This trial is currently recruiting. The enrollment target is 25,000 participants. The study started on 2025-05-30. Estimated completion is 2033-09-30.
What conditions does trial NCT07046585 study?
This clinical trial studies the following conditions: Colo-rectal Cancer.
Who is sponsoring clinical trial NCT07046585?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07046585 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colo-rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
RECRUITING · Phase 3
-
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
RECRUITING · NA
-
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
RECRUITING · Phase 2
-
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
RECRUITING · NA
-
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RECRUITING · Phase 1
-
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.